[More about miltefosine in the treatment of mucosal leishmaniasis].
Instituto de Patología Experimental, Unidad Ejecutora CONICET, CCT Salta, Salta, Argentina.
María Fernanda García
MF
Bustos
Alejandra
A
Barrio
Miguel Ángel
MÁ
Basombrío
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy*; D008297:Male; D008536:Meglumine / Q000627:therapeutic use*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010767:Phosphorylcholine / Q000031:analogs & derivatives*
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D010767:Phosphorylcholine; D008536:Meglumine